Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer

Archives of Surgery

Volumn 144, Issue 7, 2009, Pages 618-624

  Deeter, Matthew ^a   Dorer, Russell ^a   Kuppusamy, Madhan Kumar ^a   Koehler, Richard P ^a   Low, Donald E ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 67650783128     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2009.115     Document Type: Article

References (36)

1. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM; American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Spring-Verlag; 2002.
2. Union Internationale Contre le Cancer. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
3. Veeramachaneni NK, Zoole JB, Decker PA, Putnam JB Jr, Meyers BF; American College of Surgeons Oncology Group Z0060 Trial. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Ann Thorac Surg. 2008;86(2):418-421.
4. Rice TW, Blackstone EH, Rybicki LA, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg. 2003;125(5):1103-1113.
5. Rizk NP, Venkatraman E, Bains MS, et al; American Joint Committee on Cancer. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol. 2007;25(5):507-512.
6. Hofstetter W, Correa AM, Bekele N, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg. 2007;84(2):365-375.
7. Rusch VW. Should the esophageal cancer staging system be revised? J Thorac Cardiovasc Surg. 2003;125(5):992-993.
8. Royal College of Pathologists. Dataset for the Histopathological Reporting of Oesophageal Carcinoma. 2nd ed. London, England: The Royal College of Pathologists; 2006.
9. Griffiths EA, Pritchard SA, Mapstone NP, Welch IM. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology: an update for the surgical oncologist. World J Surg Oncol. 2006;4:82.
10. Hölscher AH, Bollschweiler E, Bumm R, Bartels H, Hofler H, Siewert JR. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery. 1995;118(5):845-855.
11. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus: analysis of 67 cases. Am J Surg Pathol. 1995;19(2):183-191.
12. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994;81(3):410-413.
13. Skinner DB, Dowlatshahi KD, DeMeester TR. Potentially curable cancer of the esophagus. Cancer. 1982;50(11)(suppl):2571-2575.
14. Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg. 1996;83(1):107-111.
15. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89(3):327-334.
16. Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg. 1993;80(11):1386-1388.
17. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol. 2006;32(4):413-419.
18. Royal College of Pathologists. Minimum Dataset for Oesophageal Carcinoma Histopathology Reports. London, England: Royal College of Pathologists; 1998.
19. Ibrahim NB. ACP. Best Practice No 155: guidelines for handling oesophageal biopsies and resection specimens and their reporting. J Clin Pathol. 2000;53(2):89-94.
20. Association of Directors of Anatomical and Surgical Pathology. Recommendations for the reporting of resected esophageal carcinomas. Mod Pathol. 2000;13(9):1034-1037.
21. Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg. 2007;246(1):1-8.
22. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer. 2003;88(10):1549-1552.
23. Kunisaki C, Akiyama H, Nomura M, et al. Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg. 2005;201(6):884-890.
24. Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005;103(7):1347-1355.
25. Saha S, Dehn TC. Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction. Dis Esophagus. 2001;14(1):32-36.
26. Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48(5):667-670.
27. Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg. 2008;95(2):191-194.
28. Mulligan ED, Dunne B, Griffin M, Keeling N, Reynolds JV. Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit. Eur J Surg Oncol. 2004;30(3):313-317.
29. Roh MS, Lee JI, Choi PJ. Significance of circumferential resection margin involvement following esophagectomy for esophageal cancer. Korean J Pathol. 2004;38:23-28.
30. Wu TT, Chirieac LR, Abraham SC, et al. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol. 2007;31(1):58-64.
31. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727-1733.
32. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer. 2002;94(9):2511-2516.
33. Burroughs SH, Biffin AH, Pye JK, Williams GT. Oesophageal and gastric cancer pathology reporting: a regional audit. J Clin Pathol. 1999;52(6):435-439.
34. King PM, Blazeby JM, Gupta J, Alderson D, Moorghen M. Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. J Clin Pathol. 2004;57(7):702-705.
35. Rüdiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232(3):353-361.
36. Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland; British Society of Gastroenterology; British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50(suppl 5):v1-v23.